PFE just raised its dividend On the chart it has been trending downward
as shown also by a down sloping anchored VWAP bands. Price is currently
sitting at long term support and two standard deviations below VWAP.
It appears to be ready to reverse from the deep undervalued area.
In confirmation, teh voume indicator shows moderate increased...
AstraZeneca marginally eclipsed its prior cycle highs through the 72.00 level before pulling back to suggest a potential weekly double top pattern, however, I would highlight the lack of momentum divergence at this point, which suggests to me that the current retreat is corrective. On the four-hour time frame, we can clearly see an interim 5-wave sequence has been...
$AZN on 1HR Gap FIll Needed
However it is in a downtrend right now. I am expecting a pullback.
But Be careful of news catalysts. Potential pump off of that.
What are your thoughts.
Thanks,
Kelly
AZN: The trend is still bullish in the long term but for the short term (1H) has a correction.
Observe the money management .
Follow, like, or request symbol analysis.
AZN on this Monthly timeframe is extremely bullish
More interestingly though is the inverted H&S patterns that have formed a long this 50MA line
I have counted three in this post, all leading to a bullish result
More of a creative post
Immediate targets 55, 53 and 50. Invalidation at 65. Invalidation at 70.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore...
Aridis Pharmaceuticals announced first Investor call of 2022 for today, after the closing bell.
Exiting pipeline with 2 phase 3 drugs and their monoclonal antibody cocktail.
AstraZeneca PLC (AZN) has a stake in this company.
CEO has co-developed several drug which have been sold to Astra Zeneca, Megabits and MedImmune.
Aridis Pharmaceuticals can be a potential...
Q: What has the highest probability of occurring?
After being one of the strongest performers in 2020 during the initial UK lockdown the stock lost over 30% of its value.
In 2021 it has staged a modest recovery but is still over 15% below its all time high requiring an over 20% rally.
There is well tested support at 8100p and resistance at 8775p.
There is 2...
Big pharma working with Pieris Pharmaceuticals, Inc. (PIRS):
AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments
Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments
Genentech member of RHHBY Roche Group 20Mil upfront payment and 1.4Bil potential milestone payments
SGEN Seagen 35Mil upfront payment and...
PIRS Pieris Pharmaceuticals has collaboration agreements with AstraZeneca, Boston Pharmaceuticals, Servier, Seagen and Genentech, part of Roche.
AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments
Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments
Genentech member of RHHBY Roche Group 20Mil upfront...
NASDAQ:AZN
Possible Scenario: LONG
Evidence: Price Action
TP1~ 57.
TP2 ~ ATH
Call options, Strike 60$, 09/17/21
* This is my idea and could be wrong 100%.
